Biotech Stock 365% This: Big Bet on 3-NDA Strategy
A focused $8 million investment could trigger a dramatic move in a biotech stock. Learn how three NDA filings and a d...
An introduction to wash sale rules as they apply to dividend ETFs and how to structure trades to preserve tax benefits.
17,220 articlesA focused $8 million investment could trigger a dramatic move in a biotech stock. Learn how three NDA filings and a d...
As Taysha prepares to share Q4 2025 results, investors search for clarity on cash runway, pipeline progress, and futu...
Swarmer’s 520% debut gain transformed a modest-revenue drone-software company into a market curiosity. With no analys...
XRP is carving a large pennant as traders eye a potential breakout this week. With volume shrinking, a move past $1.6...
SoundHound AI reported its sixth consecutive earnings beat as revenue and AI platform demand accelerate. The LivePers...
Capricor is at a crossroads as 2026 earnings season unfolds. This article breaks down what to look for in capricor (c...
A prominent investment advisor just made a sizable play in a well-known theme park company. This article dives into t...
A biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
Webull defied flat profits with rapid top‑line growth in Q1 2026, but costs rose sharply and regulatory headwinds loo...
As SpaceX prepares to enter the public markets, investors face a mix of hype and risk. This guide unpacks what histor...
SpaceX is eyeing a historic IPO. This guide explains the spacex date: what investors should watch, how pricing could ...
Missed the AI rally? Reasons watch MercadoLibre now. This guide breaks down three actionable catalysts, real-world sc...